Get the Stockscreener App
80.98
0.21%
-0.17
After Hours:
80.96
-0.02
-0.02%
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $80.98, with a volume of 1.22M.
It is down -0.21% in the last 24 hours and up +2.11% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$81.15
Open:
$81.58
24h Volume:
1.22M
Relative Volume:
0.74
Market Cap:
$39.78B
Revenue:
$10.19B
Net Income/Loss:
$1.05B
P/E Ratio:
38.48
EPS:
2.1044
Net Cash Flow:
$1.38B
1W Performance:
+0.86%
1M Performance:
+2.11%
6M Performance:
-9.19%
1Y Performance:
-12.28%
1-Day Range:
$80.64
$81.93
1-Week Range:
$79.81
$81.93
52-Week Range:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
80.98 | 39.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
504.22 | 179.92B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.48 | 57.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
258.31 | 37.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.20 | 36.39B | 27.43B | 1.27B | 1.01B | 1.5829 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems - Benzinga
William Blair initiates coverage on Alcon stock with Market Perform rating - Investing.com
Dry Eye Disease Market Is Booming Worldwide 2026-2033 | Novartis - openPR.com
Ideas Watch: Will Alcon Inc stock go up in YEAR2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Buyout Rumor: Does Alcon Inc stock benefit from AI growthTrade Entry Report & High Win Rate Trade Alerts - baoquankhu1.vn
Alcon - WCIV
Will Alcon Inc. stock go up in YEARJuly 2025 Volume & AI Enhanced Trading Alerts - mfd.ru
GPT Infraprojects Approved Acquisition Of 100% Stake In Alcon Builders And Engineers For 1.54 Billion Rupees - TradingView
Retail Trends: Will Alcon Inc stock go up in YEARQuarterly Risk Review & Low Risk Entry Point Guides - baoquankhu1.vn
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Myopia And Presbyopia Treatment Market Is Going to Boom | ALCON - openPR.com
Berenberg Keeps Alcon at Buy on Expected FY26 Product-supported Growth - marketscreener.com
Is Alcon Inc.'s (VTX:ALC) Recent Stock Performance Influenced By Its Financials In Any Way? - Yahoo Finance
Aug Action: Is Alcon Inc benefiting from innovation trendsJuly 2025 Movers & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Institution Moves: Is Atmos Energy Corporation currently under institutional pressureJuly 2025 Big Picture & High Accuracy Investment Signals - baoquankhu1.vn
Broadwood pushes for removal of 3 STAAR Surgical board members - MSN
ALC.SW Alcon Inc. (SIX) pre-market: CHF64.68, most active ahead of Feb earnings - Meyka
Alcon completes $750 million share repurchase program By Investing.com - Investing.com Australia
Alcon Completes $750 Million Share Repurchase Program - TradingView
ALC.SW Alcon Inc. (SIX) 20 Jan 2026: CHF62.54 close, high volume highlights outlook - Meyka
Alcon completes $750 million share repurchase program - Investing.com
Deutsche Bank Upgrades Alcon to Buy Rating, Boosts PT - marketscreener.com
Portuguese merger review of Alcon-Staar deal ends - MLex
Wet Age-Related Macular Degeneration Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research, Qilu - Barchart.com
Alcon, Trinidad Eye Hospital bring free eye care to communities - Trinidad and Tobago Newsday
The Truth About Alcon Inc.: Is This ‘Boring’ Eye Company Your Sleeper Money Move? - AD HOC NEWS
Why STAAR Surgical (STAA) Is Down 5.2% After Shareholders Reject Alcon Deal And Board Power Shifts - Yahoo Finance
STAAR CEO exits after company rejects Alcon buyout - MedTech Dive
Contact Lens Market Size to Hit USD 26.64 Billion by 2033, Driven by Rising Vision Care Awareness and Technological Advancements – SNS Insider - GlobeNewswire Inc.
STAAR Surgical (STAA) Board Restructures Amidst Alcon Deal Colla - GuruFocus
Alcon Inc.: How a Surgical Optics Powerhouse Is Quietly Redefining Vision Care - AD HOC NEWS
Stifel reiterates Hold rating on Alcon stock, maintains $80 price target - Investing.com Australia
Stifel reiterates Hold rating on Alcon stock, maintains $80 price target By Investing.com - Investing.com South Africa
Portfolio Recap: What are El Pollo Loco Holdings Inc.’s recent SEC filings showingWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Market Pulse: Can Alcon Inc stock rebound after recent weaknessTreasury Yields & AI Forecast for Swing Trade Picks - moha.gov.vn
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Stock Recap: Why Alcon Inc. stock could rally in 2025July 2025 Gainers & Free Community Consensus Stock Picks - Улправда
Staar Surgical asked Alcon to increase merger consideration - MSN
Alcon Streamlines eCOA for Patient-centric Approach - Veeva
Stifel Downgrades Alcon (ALC) and Lowers Target Price to $80.00 - GuruFocus
STAAR Surgical Stock (STAA) Opinions on Failed Alcon Merger - Quiver Quantitative
STAAR Surgical and Alcon terminate proposed merger - Eyes On Eyecare
Intraocular Lens Market Size to Reach USD 9.85 Billion by 2033, Growing at a CAGR of 6.48% - GlobeNewswire Inc.
Stifel downgrades Alcon stock to Hold on UNITY survey concerns - Investing.com
Stifel downgrades Alcon stock to Hold on UNITY survey concerns By Investing.com - Investing.com Nigeria
How sustainable is Alcon Inc. stock dividend payoutJuly 2025 Setups & AI Optimized Trade Strategies - ulpravda.ru
Alcon Inc.'s (VTX:ALC) Intrinsic Value Is Potentially 56% Above Its Share Price - Yahoo Finance
Is Alcon Inc. stock trading at a premium valuationEarnings Summary Report & Scalable Portfolio Growth Methods - ulpravda.ru
Is Alcon Inc. stock a buy on dipsMarket Growth Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):